Market by Product, Application, End-user, and Country | Forecast 2021-2028
According to Triton, the digital genome market in Latin America is expected to prosper with a CAGR of 6.35% in the forecast period from 2021 to 2028.
Report scope can be customized per your requirements. Request For Customization
The countries
scrutinized in this market include:
• Brazil
• Mexico
• Rest of Latin America countries
In 2011, Mexico
instituted the Genomic Sovereignty Act, which regulates research on the human
genome. By implementing this act, the government has established regulations
for exporting DNA samples from Mexican citizens for population genetics
studies. It supports the development of a bio-economy and genome-based medical
biotechnology. Enormous efforts from the government and the private sector
enabled the creation and operation of the National Institute of Genomic
Medicine (INMEGEN) in the country. The institute aims to initiate and work on
projects based on the genome of the people of Mexico, and implement the public
health and medical applications of genomics.
The genetic testing
market in Mexico is expected to witness accelerated growth in the forecast
period, mainly because of the rising number of government initiatives promoting
genetic testing and the inherent genetic diversity of people of Mexican
descent. Besides, in 2020, several research studies were conducted in the
country to study the severity of Coronavirus infection. Reports suggest that a
diagnostic test for COVID-19 was first conducted in Mexico City on February 27,
2020, at the Instituto Nacional de Enfermedades Respiratorias. Hence, the
studies related to the Coronavirus strain and the other genomic projects going
on in the country are expected to fuel the Mexican digital genome market’s
growth in the forecast period.
F. Hoffmann-La Roche
Ltd is a healthcare company engaged in developing and commercializing
innovative diagnostic and therapeutic products. It manufactures pharmaceutical
products having applications in various therapeutic areas, such as immunology,
oncology, infectious diseases, ophthalmology, and neuroscience. The company’s
list of end-users includes commercial diagnostic laboratories, hospitals,
healthcare professionals, researchers, and pharmacists. Founded in 1896, Roche
has business operations in Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA DIGITAL GENOME MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON DIGITAL GENOME MARKET
2.3. MARKET
ATTRACTIVENESS INDEX
2.4. VENDOR
LANDSCAPE
2.5. KEY
INSIGHTS
2.6. KEY
DRIVERS
2.6.1. PROLIFERATING
BURDEN OF CHRONIC DISEASES
2.6.2. CONTINUOUS
FUNDING BY THE MANUFACTURERS AND GOVERNMENT IN THE FIELD OF GENOMICS
2.7. KEY
RESTRAINTS
2.7.1. SECURITY
RISKS ASSOCIATED WITH DIGITAL GENOME
2.7.2. LACK
OF SKILLED PROFESSIONALS IN THE FIELD OF GENOME TECHNOLOGY
2.8. KEY
OPPORTUNITIES
2.8.1. TECHNOLOGICAL
ADVANCEMENTS
2.8.2. PREVAILING
AWARENESS IN THE DEVELOPING ECONOMIES REGARDING DNA SEQUENCING TECHNOLOGIES
3. DIGITAL
GENOME MARKET OUTLOOK - BY PRODUCT
3.1. SEQUENCING
AND ANALYZER INSTRUMENTS
3.2. DNA/RNA
ANALYSIS
3.3. SEQUENCING
AND ANALYSIS SOFTWARE
3.4. SEQUENCING
CHIPS
3.5. SAMPLE
PREP INSTRUMENTS
4. DIGITAL
GENOME MARKET OUTLOOK - BY APPLICATION
4.1. DIAGNOSTICS
4.2. DRUG
DISCOVERY
4.3. ACADEMIC
RESEARCH
4.4. PERSONALIZED
MEDICINE
4.5. AGRICULTURAL
4.6. OTHER
APPLICATIONS
5. DIGITAL
GENOME MARKET OUTLOOK - BY END-USER
5.1. DIAGNOSTICS
AND FORENSIC LABS
5.2. ACADEMIC
RESEARCH INSTITUTES
5.3. HOSPITALS
5.4. OTHER
END-USERS
6. DIGITAL
GENOME MARKET - LATIN AMERICA
6.1. COUNTRY
ANALYSIS
6.1.1. MEXICO
6.1.2. BRAZIL
6.1.3. REST
OF LATIN AMERICA
7. COMPANY
PROFILE
7.1. QIAGEN
NV
7.2. OXFORD
NANOPORE TECHNOLOGIES LTD
7.3. BECTON,
DICKINSON, AND COMPANY (BD)
7.4. ILLUMINA
INC
7.5. THERMO
FISHER SCIENTIFIC INC
7.6. PACIFIC
BIOSCIENCE
7.7. BIO-RAD
LABORATORIES INC
7.8. F.
HOFFMANN-LA ROCHE
7.9. PERKINELMER
INC
7.10. REGENERON
PHARMACEUTICALS
7.11. BIOMERIEUX
SA
7.12. ABBOTT
LABORATORIES
7.13. AGILENT
TECHNOLOGIES INC.
7.14. INSCRIPTA
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: LATIN AMERICA DIGITAL GENOME MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR LANDSCAPE
TABLE 3: LATIN AMERICA DIGITAL GENOME MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 4: LATIN AMERICA DIGITAL GENOME MARKET, BY APPLICATION,
2021-2028 (IN $ MILLION)
TABLE 5: LATIN AMERICA DIGITAL GENOME MARKET, BY
END-USER, 2021-2028 (IN $ MILLION)
TABLE 6: LATIN AMERICA DIGITAL GENOME MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: LATIN AMERICA DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE 2: LATIN AMERICA DIGITAL GENOME MARKET, BY
SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 3: LATIN AMERICA DIGITAL GENOME MARKET, BY
DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)
FIGURE 4: LATIN AMERICA DIGITAL GENOME MARKET, BY
SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA DIGITAL GENOME MARKET, BY
SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA DIGITAL GENOME MARKET, BY
SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA DIGITAL GENOME MARKET, BY
DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA DIGITAL GENOME MARKET, BY
DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA DIGITAL GENOME MARKET, BY
ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA DIGITAL GENOME MARKET, BY
PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA DIGITAL GENOME MARKET, BY
AGRICULTURAL, 2021-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA DIGITAL GENOME MARKET, BY OTHER
APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA DIGITAL GENOME MARKET, BY
DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA DIGITAL GENOME MARKET, BY
ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA DIGITAL GENOME MARKET, BY
HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA DIGITAL GENOME MARKET, BY OTHER
END-USERS, 2021-2028 (IN $ MILLION)
FIGURE 17: LATIN AMERICA DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE 18: MEXICO DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 19: BRAZIL DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 20: REST OF LATIN AMERICA DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)